Nasdaq

AIM ImmunoTech Files Provisional Patent Application for Ampligen as an Early-Onset Intranasal Therapy that May Also Confer Enhanced Immunity to a Wide Range of Respiratory Viruses

OCALA, Fla., Sept. 27, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced the filing of a provisional patent application for Ampligen as a potential early-onset ...
Insurancenewsnet.com

“Diabetes Onset And Progression Prediction Using A Computerized Model” in Patent Application Approval Process (USPTO 20230035564): Patent Application

This patent application has not been assigned to a company or institution. The following quote was obtained by the news editors from the background information supplied by the inventors: “The world ...
Insurancenewsnet.com

Researchers Submit Patent Application, “Diagnostic Method for Pediatric Acute-Onset Neuropsychiatric Syndrome (Pans) and Pediatric Autoimmune…

As a supplement to the background information on this patent application, NewsRx correspondents also obtained the inventors' summary information for this patent application: "The present invention ...